Dolby Laboratories (DLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2016 | 03-2016 | 12-2015 | 09-2015 | 06-2015 | |
| Sales | 277,587 | 274,340 | 240,814 | 232,748 | 231,702 |
| Cost of Goods | 24,621 | 24,373 | 29,766 | 25,377 | 24,880 |
| Gross Profit | 252,966 | 249,967 | 211,048 | 207,371 | 206,822 |
| Operating Expenses | 172,392 | 168,013 | 172,626 | 171,611 | 162,757 |
| Operating Income | 81,195 | 82,327 | 39,188 | 36,137 | 44,945 |
| Interest Expense | 26 | 33 | 29 | 68 | 69 |
| Other Income | 615 | 1,529 | 325 | 28,134 | 2,502 |
| Pre-tax Income | 81,784 | 83,823 | 39,484 | 64,203 | 47,378 |
| Income Tax | 18,017 | 16,278 | 8,473 | 17,288 | 11,522 |
| Net Income Continuous | 63,767 | 67,545 | 31,011 | 46,915 | 35,856 |
| Minority Interests | 139 | 147 | 110 | 362 | 350 |
| Net Income | $63,628 | $67,398 | $30,901 | $46,553 | $35,506 |
| EPS Basic Total Ops | 0.63 | 0.67 | 0.31 | 0.45 | 0.35 |
| EPS Basic Continuous Ops | 0.63 | 0.67 | 0.31 | 0.46 | 0.35 |
| EPS Diluted Total Ops | 0.62 | 0.66 | 0.30 | 0.45 | 0.34 |
| EPS Diluted Continuous Ops | 0.62 | 0.67 | 0.30 | 0.45 | 0.34 |
| EBITDA(a) | $102,734 | $104,486 | $62,607 | $56,441 | $64,547 |